Kane Biotech Inc. (KNE) Receives Approval from Health Canada for Hard Surface Disinfectant
10/12/2011 6:50:13 AM
More...
|
Kane Biotech Inc. (KNE) Release: DispersinB(R) Wound Spray Passes Final Biocompatibility Sub-Chronic Toxicity Test
1/26/2011 10:31:47 AM
More...
|
Kane Biotech Inc. (KNE) Announces Grant of Options
1/19/2011 10:12:45 AM
More...
|
Kane Biotech Inc. (KNE) Retains Pure Advertising & Marketing for Investor Relations
1/13/2011 9:54:25 AM
More...
|
Kane Biotech Inc. (KNE) Receives $100,000 in Financial Assistance from the Government of Manitoba
12/15/2010 9:43:26 AM
More...
|
Kane Biotech Inc. (KNE) Issued US Patent for DispersinB(R) Wound Care Technology
11/16/2010 11:12:28 AM
More...
|
Kane Biotech Inc. (KNE)'s DispersinB(R) Topical Wound Spray Passes Critical Sensitization Test
11/8/2010 9:54:00 AM
More...
|
Kane Biotech Inc. (KNE) Appoints Board Advisor and Announces Private Placement Offering
11/2/2010 9:43:13 AM
More...
|
Kane Biotech Inc. (KNE)'s DispersinB(R) Wound Spray Passes First Set of Biocompatibility Tests
10/4/2010 9:38:01 AM
More...
|
Kane Biotech Inc. (KNE)'s DispersinB(R) Wound Spray Passes Quality Control and Sterility Tests
9/30/2010 9:25:41 AM
More...
|
|